milgamma® 300mg film-coated tablets
MILGAMMA 300 mg Active ingredient: benfotiamine (thiamine prodrug) and vitamin B6.
MILGAMMA 300 mg Areas of application:
Neurological systemic diseases due to a proven deficiency of vitamins B1 and B6.
Contraindications:
Suspected thiamine hypersensitivity, otherwise no known contraindications.
Side effects:
In individual cases allergic hypersensitivity reactions with skin reactions, hives (urticaria), states of shock.
Use during pregnancy and lactation:
No evidence of teratogenicity or mutagenicity. No concerns during breastfeeding in the specified dose range.
MILGAMMA 300 mg Interactions with other agents:
Therapeutic doses of vitamin B6 can weaken the effects of L-Dopa.
Further interactions exist with INH, D-penicillamine, cycloserine.